Medical/Pharmaceuticals
Interaxon Partners with Celéri Health to Validate Chronic Pain Intervention
TORONTO, July 20, 2021 /PRNewswire/ -- Interaxon, along with Celéri Health and pain expert Dr.Ronald D. Siegel, is testing a therapeutic intervention to help people better manage their chronic and acute pain. With the prevalence of pain and its multidimensional repercussions, this non-opioid alte...
2021-07-20 21:00
1733
Everest Medicines Announces Strategic Collaboration with MediTrust Health Co., Ltd to Develop Novel Payment Solutions for Patients in China
SHANGHAI, July 20, 2021 /PRNewswire/ -- Everest Medicines
2021-07-20 18:42
6213
Juventas Cell Therapy Ltd. Closes Series C Financing to Advance the "Rapid Commercialization and Internationalization" Development Strategy
TIANJIN, China, July 20, 2021 /PRNewswire/ -- Juventas Cell Therapy Ltd., a Chinese biopharmaceutical company announced the close of a $60 million+ Series C financing led by CICC Capital and Oceanpine Capital. The co-investors include Delian Capital and existing investors such as Jiadao Private C...
2021-07-20 10:47
2216
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcomes
The company employs real-world data and evidence to accelerate research through targeted site and patient recruitment strategies SANTA CLARA, Calif., July 20, 2021 /PRNewswire/ -- Based on its recent analysis of the global clinical research organization (CRO) market,Frost & Sullivan recognizes l...
2021-07-20 01:47
2244
RedHill Biopharma Announces Last Patient Out for Phase 2/3 COVID-19 Study of Oral Opaganib
Patient follow-up completed for the 475-patient global Phase 2/3 study of oral opaganib for severe COVID-19 Top-line results expected in the coming weeks Opaganib, a novel, dual antiviral and anti-inflammatory investigational COVID-19 pill, demonstratedpotent inhibition of Beta and Gamma variant...
2021-07-19 19:21
18115
Ascentage Pharma Establishes Cooperative R&D Agreement (CRADA) with the National Cancer Institute for Clinical Development of Ascentage Pharma's Drug Compound pelcitoclax
SUZHOU, China, and ROCKVILLE, Md., July 19, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company has entered into a Cooperative ...
2021-07-19 18:41
4500
Frontier Biotechnologies' First Long-acting Injectable (Aikening(R)), in a Two Drug Regimen for HIV, Proves Safe and Efficacious for Patients
* The TALENT study (TALENT) findings, which were presented at the 11th International AIDS Society (IAS) Conference on HIV Science, showed that a two-drug regimen was as effective and safe as multi-drug therapies * TALENT is the world's first phase III clinical trial of the new long-acting HIV...
2021-07-19 16:23
3652
GoTo Group and partners create Indonesia's first dedicated oxygen facility for COVID-19 patients
* "Gotong Royong Oxygen House" to be set up in collaboration with KADIN Indonesia and Samator Group * Oxygen to be piped direct from Samator Group's oxygen production facility, ensuring a reliable and uninterrupted supply * Initiative set to relieve pressure on Jakarta hospitals as the COVID...
2021-07-19 15:16
2120
SonoScape's X5 is aboard to deliver ultrasound imaging in Space
SHENZHEN, China, July 19, 2021 /PRNewswire/ -- On June 17th, the Shenzhou-12 spacecraft consisting of a crew of three was launched into space, taking one step forward to establishChina's Tiangong space station which is under construction in a Low-Earth orbit. Astronauts will stay in space for thr...
2021-07-19 15:10
4120
Parkinson's UK Implements CDD Vault to Manage Its Pioneering Drug Discovery Data
LONDON and SAN FRANCISCO, July 19, 2021 /PRNewswire/ -- Parkinson's UK, the largest charitable funder of Parkinson's research inEurope, has announced today that it is using Collaborative Drug Discovery'sCDD Vault informatics system to manage project data from theParkinson's Virtual Biotech, its p...
2021-07-19 14:57
1706
YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE
BEIJING, July 19, 2021 /PRNewswire/ -- YishengBio Co., Ltd ("YishengBio") today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase I clinical trial from United Arab Emirates Ministry of Health & Prevention. PIKA recombinant COVID-19 vaccine is a PI...
2021-07-19 09:00
3620
Bioelectronica Announces Hypercell™ Expansion for Antibody Discovery, Closing of Oversubscribed Series A Financing, Powering Local Hiring Growth and Expansion of Facilities in Reno
RENO, Nev., July 19, 2021 /PRNewswire/ -- Bioelectronica® Corporation ("Bioelectronica") announced today that it has secured an undisclosed amount in its Series A financing round due to increased interest in Hypercell™, a new hardware tool that can be used to discover new antibodies using compute...
2021-07-19 08:59
3450
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI319 (Anti-PD-1/CD137 Bispecific Antibody) in Patients with Advanced Malignant Tumors
SAN FRANCISCO and SUZHOU, China, July 16, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-07-16 08:00
9183
Fortacin™ Receives Strong Positive Results for US Phase II PRO Validation Study
HONG KONG, July 15, 2021 /PRNewswire/ -- Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to announce the successful completion of prespecified data analysis fromthe United States study mandated patient ...
2021-07-15 21:27
38589
Atonarp announces innovative new metrology platform Aston, aimed at increasing yield, throughput, and efficiency in semiconductor manufacturing processes
TOKYO, July 15, 2021 /PRNewswire/ -- Atonarp, a leading manufacturer of molecular sensing and diagnostics products for the semiconductor, healthcare, and pharma industries, today announcedAston, an innovative in-situ semiconductor metrology platform with an integrated plasma ionization source. ...
2021-07-15 21:15
4329
ELITechGroup Acquires GONOTEC, A Leading Market Player In Freezing Point Osmometry
LOGAN, Utah, July 15, 2021 /PRNewswire/ -- ELITechGroup, market leader in global vapor pressure osmometer technology, announces the acquisition of GONOTEC, a leading market player in freezing point osmometer technology. The purchase of the company unites two osmometry market leaders, providing t...
2021-07-15 20:00
3618
Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on July 22 at 9:30 CEST
STOCKHOLM, July 15, 2021 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFOElisabet Lund. To register for the presentation of the ...
2021-07-15 16:20
1701
Cigna International finds community spirit and duty to society top driver of COVID-19 vaccine uptake
Key research findings: * Vaccine acceptance continues to improve – steady increase in vaccine acceptance, 69% up from 63% in three months * Urgency has increased – those waiting to get a vaccination until more people have had their first one dropped 8% in three months, from 50% to 42% * Vac...
2021-07-15 15:30
46236
Transcenta Announces First Patient Dosed in Global Phase I Clinical Trial of PD-L1/TGF-β Bi-functional Antibody TST005
SUZHOU, China, July 15, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announces that the first US patient has been dosed...
2021-07-15 11:23
3003
Ascentage Pharma and Innovent Biologics Reach Multifaceted Strategic Agreement Totaling US$245 Million Including Commercialization of Olverembatinib (HQP1351) in China, Joint Clinical Development of Lisaftoclax (APG-2575) and Equity Investment
SUZHOU, China, and ROCKVILLE, Md., July 14, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, and Innovent Biologics (1801.HK, "Innovent"), today an...
2021-07-15 01:43
6444
Week's Top Stories
Most Reposted
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 308 media titles]
2026-05-19 18:10
Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 307 media titles]
2026-05-19 23:59
Hong Leong Bank Awarded Best Managed Bank in Malaysia by The Asian Banker, Group MD/CEO Kevin Lam Named Best Bank CEO in Malaysia
[Picked up by 293 media titles]
2026-05-15 17:00
Hyundai Motor Group to Pioneer Hong Kong's Hydrogen Economy, Accelerating Asia-Pacific Expansion
[Picked up by 289 media titles]
2026-05-18 15:30
AIMX Singapore 2026 Anchors Strategic Relationship with TechInnovation and AI Gravity
[Picked up by 279 media titles]
2026-05-19 14:00
Most Read
H World Group Reports Q1 Results, Highlighting Asset-light Growth and Expanding APAC Footprint
2026-05-15 20:11
7995
